Qi Liu

4.8k citations
109 papers · 3.3k indexed · h-index 30
  • Immunology top 2%
    • Immune Cell Function and Interaction 14
    • Immunotherapy and Immune Responses 12
    • Immune cells in cancer 11
    • Aquaculture disease management and microbiota 9
    • interferon and immune responses 8
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers 8
    • Inflammasome and immune disorders 10
    • Cancer-related gene regulation 7

Qi Liu

103 papers receiving 3.3k citations

Peers

Qi Liu
Comparison fields: 5 of 151
  • Immunology 1.2k
  • Pharmaceutical Science 153
  • Oncology 668
  • Molecular Biology 1.5k
  • Cancer Research 256
Replace Thomas Schwarz with:
Thomas Schwarz Germany
Honnavara N. Ananthaswamy United States
Dagmar Kulms Germany
Min Luo China
Wei Wu China
Yusuf Baran Türkiye
Gary M. Halliday Australia
Ajaz A. Bhat India
Stephen E. Ullrich United States
James A. Mobley United States
Qi Liu relative to Thomas Schwarz Germany Thomas Schwarz's profile →
Citations per field
00.5×2.8×
Thomas Schwarz · 1×
Citations per year

Countries citing papers authored by Qi Liu

Since Specialization
Citations

This map shows the geographic impact of Qi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Liu more than expected).

Fields of papers citing papers by Qi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Liu. The network helps show where Qi Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Qi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qi Liu Line = papers co-authored together Qi Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20243
3 20231
4 20233
5 202326
6 202210
7 20222
8 202117
9 202136
10 202133
11 20217
12 202043
13 202011
14 20172
15 2017128
16 20171
17 20171
18 20139
19 201230
20
Epidemiological investigation and integrated management of rabies in Guangxi province.
20101

About Qi Liu

Qi Liu is a scholar working on Immunology, Virology and Molecular Biology, having authored 109 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (12 papers), Immune cells in cancer (11 papers), Inflammasome and immune disorders (10 papers), Aquaculture disease management and microbiota (9 papers), interferon and immune responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Immunology (1.2k citations), Pharmaceutical Science (153 citations) and Oncology (668 citations). Qi Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Leaf Huang, Sara Musetti, Manisit Das, Yun Liu, Jun Li, Yuhua Wang, Lei Miao, Lina Liu, Limei Shen and Zhen Gu.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026